Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.25.0.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:      
Accrued expenses and reserves $ 456 $ 1,992  
Capitalized research and development expenses 4,528 2,241  
Tax credit carryforwards 243 240  
Deferred revenue 1,367 1,217  
Net operating loss carryforwards 38,676 20,371  
Interest disallowance 10,007 6,640  
Equity-based compensation 2,643 1,580  
Lease liability 4,956 4,454  
Other assets 62 54  
Total deferred tax assets 62,938 38,789  
Less: valuation allowance (45,324) (23,821) $ (19,013)
Deferred tax assets, net of valuation allowance 17,614 14,968  
Deferred tax liabilities:      
Right-of-use asset (4,291) (3,725)  
Depreciation and amortization (13,616) (13,523)  
Other (217) (122)  
Deferred tax liabilities (18,124) (17,370)  
Total net deferred tax assets (liabilities) $ (510) $ (2,402)